Allergan plc (AGN) stock observed trading -14.59% off 52-week high price. On the other end, the stock has been noted 47.24% away from low price over the last 52-weeks. The stock disclosed a move of 3.95% away from 50 day moving average and 13.61% away from 200 day moving average. Moving closer, we can see that shares have been trading 2.36% off 20-day moving average. It has market cap of $55152.35M and dividend yield of 1.76%.
Allergan plc (AGN) recently reported that, as predictable, Allergan and AbbVie (NYSE: ABBV) have each received a Request for Additional Information and Documentary Material (Second Request) from the U.S. Federal Trade Commission (FTC) in connection with AbbVie’s pending acquisition of Allergan.
The Second Request was issued under notification requirements of the Hart-Scott-Rodino (HSR) Antitrust Improvements Act of 1976, as amended. The Second Request extends the waiting period under the HSR Act until 30 days after both Allergan and AbbVie have substantially complied with the Second Request. Allergan and AbbVie are cooperating fully with the FTC and continue to expect to close the transaction in early 2020.
The USA based company Allergan plc moved with change of 0.81% to $168.25 with the total traded volume of 2433992 shares in recent session versus to an average volume of 4125.25K. The stock was observed in the 5 days activity at 1.07%. The one month performance of stock was 5.17%. AGN’s shares are at 0.49% for the quarter and driving a -11.66% return over the course of the past year and is now at 25.88% since this point in 2018. Right now the stock beta is 1.65. The average volatility for the week and month was at 0.93% and 0.92% respectively. There are 327.8M shares outstanding and 327.17M shares are floated in market.